Betahistine dihydrochloride tor (racemic) DTXSID60385481

DTXSID60385481

hematocrit

MLN2238 (7 mg/kg) shows greater efficacy at a 0

[3] Ultraviolet-A (UVA)-irradiated 1% Ampiroxicam sensitized in guinea pigs shows positive reaction in the patch testing to UVA-irradiated 1% Ampiroxicam and 1% thiosalicylate (TOS)

Caltabiano M

Betahistine dihydrochloride tor (racemic) DTXSID60385481Betahistine is a histamine analog and H1 receptor agonist that serves as a vasodilator. It is used in MENIERE DISEASE and in vascular headaches but may exacerbate bronchial asthma and peptic ulcers. Betahistine dihydrochloride is an anti vertigo drug. It is commonly prescribed for balance disorders or to alleviate vertigo symptoms associated with Mnire's disease. It was first registered in Europe in 1970 for the treatment of Mnire's disease. Product